Biotech Strategy Blog Cancer Conferences New Products

Hematology Winners and Losers at ASCO20

Which hematology products in development produced the best data at ASCO 2020? We took a look at the key studies in lymphomas and myelomas to find out.

View post

A rock around the breast cancer clock

Highlights from various breast cancer trials and new pipeline developments

View post

Can we add fire to the immune system with TIGIT?

A look at Genentech's tiragolumab (anti-TIGIT) in advanced lung cancer

View post

error: Content is protected !!

Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

Hematology Winners and Losers at ASCO20

A rock around the breast cancer clock

Can we add fire to the immune system with TIGIT?

A false dawn in adjuvant EGFR mutant lung cancer? Dr Ross Camidge provides a critical review of ADAURA

Reflections on bench to bedside progress

What to watch out for in Developmental Therapeutics at ASCO20

Highlighting an under-rated clinical development at ASCO20

Hematology Winners and Losers at ASCO20

A rock around the breast cancer clock

Can we add fire to the immune system with TIGIT?